My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
STFC slips in volatile trade after raising funds
Mar 30,2017

The announcement was made after market hours yesterday, 29 March 2017.

Meanwhile, the S&P Sensex was up 96.90 points, or 0.33% at 29,628.33.

On the BSE, 11,000 shares were traded on the counter so far as against the average daily volumes of 41,013 shares in the past one quarter. The stock was volatile. The stock had hit a high of Rs 1,084.40 and a low of Rs 1,052 so far during the day.

The stock had hit a record high of Rs 1,325 on 1 August 2016 and a 52-week low of Rs 778 on 26 December 2016. The stock had outperformed the market over the past one month till 29 March 2017, advancing 14.29% compared with the Sensexs 2.74% rise. The scrip had also outperformed the market over the past one quarter advancing 27.56% as against the Sensexs 12.01% rise.

The large-cap company has equity capital of Rs 226.88 crore. Face value per share is Rs 10.

Shriram Transport Finance Company (STFC) said that the allotment committee non-convertible debentures (NCDs) of the company has approved and allotted 11,000 Secured Redeemable Rated Listed Non-Convertible Debenture of face value of Rs 10 lakh each, aggregating to Rs 1100 crore on private placement basis.

Shriram Transport Finance Companys net profit fell 7.8% to Rs 345.96 crore on 5.8% increase in total income to Rs 2717.43 crore in Q3 December 2016 over Q3 December 2015.

Shriram Transport Finance Company is one of the leading asset financing non-banking financial companies (NBFC) in India.

Powered by Capital Market - Live News

IndusInd Bank nudges higher after action from foreign funds
Mar 30,2017

Meanwhile, the S&P BSE Sensex was up 84.92 points or 0.29% at 29,616.35.

On the BSE, 5,422 shares were traded on the counter so far as against the average daily volumes of 1.49 lakh shares in the past one quarter. The stock had hit a high of Rs 1,414.95 and a low of Rs 1,399 so far during the day. It had hit a record high of Rs 1,425 on 28 March 2017 and a 52-week low of Rs 912 on 28 March 2016.

The large-cap bank has equity capital of Rs 598.15 crore. Face value per share is Rs 10.

Macquarie Bank sold 35.32 lakh shares of IndusInd Bank at Rs 1,409.50 in a bulk deal on the BSE on 29 March 2017. Tybourne Equity Master Fund bought 30.07 lakh shares. Goldman Sachs Investments Mauritius I sold 71.38 lakh shares at Rs 1,400.19 per share in a bulk deal on the NSE on 29 March 2017. Tybourne Equity Master Fund bought 42.38 lakh shares at Rs 1,400 a piece. Goldman Sachs Investments Mauritius I controlled 1.61% stake end December 2016.

Meanwhile, IndusInd Bank said it has extended its agreement with Lohia Industries by offering 3-wheeler financing in the e-rickshaw category. Lohia Auto Industries announced that IndusInd Bank would be its preferred financier for financing their electric three wheelers under the e-rickshaw category. This is in addition to the financing of diesel vehicles which the bank already provides.

Through this partnership IndusInd Bank will offer retail vehicle finance at attractive rates of interest to the customers of Lohia Auto, for all Lohia 3-wheeler electronic and diesel models. This partnership will simplify the process for customers to take up three-wheeler by providing loans which are hassle free and competitively priced. The announcement was made after market hours yesterday, 29 March 2017.

The memorandum of understanding (MoU) between IndusInd Bank and Lohia Auto Industries was signed in May 2016 for diesel vehicles and has now been extended to the electronic 3-wheeler segment. Since May 2016, IndusInd Bank has financed close to 7.10 lakh 3-wheeler vehicles as a part of this association.

IndusInd Banks net profit rose 29.2% to Rs 750.64 crore on 22.9% growth in total income to Rs 4716.13 crore in Q3 December 2016 over Q3 December 2015.

IndusInd Bank is a leading private sector bank in India.

Powered by Capital Market - Live News

Alkem Lab moves higher after receiving EIR for facility
Mar 30,2017

The announcement was made after market hours yesterday, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 85.40 points or 0.29% at 29,616.83.

On the BSE, 1,248 shares were traded on the counter so far as against the average daily volumes of 9,467 shares in the past one quarter. The stock had hit a high of Rs 2,195 and a low of Rs 2,165 so far during the day. It had hit a record high of Rs 2,225 on 28 March 2017 and a 52-week low of Rs 1,175 on 2 May 2016.

The large-cap company has equity capital of Rs 23.91 crore. Face value per share is Rs 2.

Alkem Laboratories said that the United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the companys active pharmaceutical ingredient (API) manufacturing facility located at Ankaleshwar, which was inspected in December 2016.

The inspection has now been closed by the USFDA. In response to the Form 483 issued by the USFDA, the company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The USFDA has reviewed the CAPA and has found them acceptable.

Alkem Laboratories consolidated net profit rose 24.9% to Rs 233.40 crore on 15% growth in net sales to Rs 1462.23 crore in Q3 December 2016 over Q3 December 2015.

Alkem Laboratories is a pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Powered by Capital Market - Live News

RIL inches up after completing stake sale in GAPCO
Mar 30,2017

The announcement was made after market hours yesterday, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 70.06 points or 0.24% at 29,601.49.

On the BSE, 19,000 shares were traded on the counter so far as against the average daily volumes of 1.97 crore shares in the past one quarter. The stock had hit a high of Rs 1,266.20 and a low of Rs 1,254.05 so far during the day. It had hit a 52-week high of Rs 1,326.75 on 7 March 2017 and a 52-week low of Rs 925.70 on 23 May 2016.

The large-cap company has equity capital of Rs 3251.28 crore. Face value per share is Rs 10.

Pursuant to the sale agreements signed by Reliance Exploration & Production DMCC (REPDMCC), an indirect wholly owned subsidiary of Reliance Industries (RIL) and TOTAL, for the sale of the entire 76% interest held by REPDMCC in the Mauritius-incorporated Gulf Africa Petroleum Corporation (GAPCO), REPDMCC, TOTAL and GAPCO have obtained requisite regulatory approvals, consents and successfully completed the sale transaction.

GAPCO is a holding company with operating subsidiaries in Tanzania, Kenya and Uganda which are primarily engaged in petroleum product import, and trading, storage, distribution, marketing, supply and transportation of oil products in East Africa.

Since the acquisition of 76% equity interest in GAPCO by REPDMCC in 2007, GAPCO has significantly grown and is one of leading petroleum marketing company in East Africa owning retail outlets as well as onshore and offshore terminals.

REPDMCCs sale of its interest in GAPCO is pan of a joint transaction, wherein REPDMCC as well as the minority shareholder have sold their entire respective holdings in GAPCO for cash.

RILs consolidated net profit rose 3.6% to Rs 7506 crore on 17.6% growth in net sales to Rs 79408 crore in Q3 December 2016 over Q3 December 2015.

Reliance Industries (RIL) is Indias largest private sector company. RILs activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, retail and telecommunications.

Powered by Capital Market - Live News

V-Mart Retail attracts buyers after opening new store
Mar 29,2017

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 69.05 points or 0.23% at 29,478.57. The S&P BSE Small-Cap index was up 30.05 points or 0.21% to 14,183.42.

More than usual volumes were witnessed on the counter. On the BSE, 61,653 shares were traded on the counter so far as against the average daily volumes of 29,745 shares in the past one quarter. The stock had hit a high of Rs 847.30 and a low of Rs 788 so far during the day. The stock had hit a record high of Rs 883.75 on 9 March 2017. The stock had hit a 52-week low of Rs 425 on 24 June 2016.

The small-cap company has equity capital of Rs 18.07 crore. Face value per share is Rs 10.

V-Mart Retail said that the store is a fashion store. With the opening of the store, the tally of stores in Bihar is 5 composite & 26 fashion stores. This takes the total number of stores to 141 stores in 121 cities across 14 states, with 37 composite stores & 104 fashion stores with a total area of around 11.95 lakhs square feet.

V-Mart Retail net profit rose 81.3% to Rs 27.21 crore on 23.2% growth in net sales to Rs 326.49 crore in Q3 December 2016 over Q3 December 2015.

V-Mart Retail is a hypermarket format retail chain based in New Delhi. It is a multi-brand family retail store offering apparels, general merchandise and kirana.

Powered by Capital Market - Live News

Panacea Biotec in pink of health after launching vaccine
Mar 29,2017

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 105.96 points, or 0.36% to 29,515.48. The S&P BSE Small-Cap index was up 60.44 points or 0.43% to 14,213.81.

On the BSE, 39,933 shares were traded in the counter so far, compared with average daily volumes of 47,302 shares in the past one quarter. The stock had hit a high of Rs 167.80 and a low of Rs 153.05 so far during the day. The stock had hit a 52-week high of Rs 178.30 on 27 January 2017. The stock had hit a 52-week low of Rs 85.50 on 26 May 2016.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Re 1.

Panacea Biotec said the vaccine was researched, developed and manufactured by the company in India. EasySix is indicated for primary immunization to protect newborn babies against six preventive diseases namely, Diptheria, Tetanus, Whopping Cough, Hepatitis B and Polio.

Panacea Biotec reported net loss of Rs 29.25 crore in Q3 December 2016, higher than net loss of Rs 17.38 crore in Q3 December 2015. Net sales declined 34% to Rs 99.33 crore in Q3 December 2016 over Q3 December 2015.

Panacea Biotec is one of Indias leading research based biotechnology companies with established research, manufacturing and marketing capabilities.

Powered by Capital Market - Live News

Dishman Pharmaceuticals & Chemicals leads gainers in A group
Mar 29,2017

Dishman Pharmaceuticals & Chemicals jumped 10.17% at Rs 306.50 at 13:45 IST with the stock extending Tuesdays rally amid media reports surrounding US drug regulators approval for a cancer drug.. The stock topped the gainers in the BSEs A group. On the BSE, 21.83 lakh shares were traded on the counter so far as against the average daily volumes of 1.7 lakh shares in the past two weeks. Dish Pharma clarified that since it does not manufacture the innovators end product in contract research and manufacturing services (CRAMS) segment, it is Tesaro Inc., which has received the USFDA approval for cancer drug Zejula Capsules and not Dishman Pharma as mentioned in media reports.

Edelweiss Financial Services jumped 6.54% at Rs 155.55. The stock was the second biggest gainer in A group. On the BSE, 16.57 lakh shares were traded on the counter so far as against the average daily volumes of 47.37 lakh shares in the past two weeks.

Cox & Kings gained 6.22% to Rs 221.90. The stock was the third biggest gainer in A group. On the BSE, 5.03 lakh shares were traded on the counter so far as against the average daily volumes of 45,000 shares in the past two weeks.

Shipping Corporation of India rose 6.14% at Rs 73.50. The stock was the fourth biggest gainer in A group. On the BSE, 8.8 lakh shares were traded on the counter so far as against the average daily volumes of 9.94 lakh shares in the past two weeks.

Muthoot Finance rose 5.13% to Rs 369. The stock was the fifth biggest gainer in A group. On the BSE, 1 lakh shares were traded on the counter so far as against the average daily volumes of 25,000 shares in the past two weeks.

Powered by Capital Market - Live News

UCO Bank nudges higher on capital raising plans
Mar 29,2017

The issue is a private placement of unsecured redeemable non-convertible fully paid up Basel III compliant tier II bonds in the nature of debentures.

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 88.02 points, or 0.3% to 29,497.54. The S&P BSE Mid-Cap index was up 39.80 points or 0.29% to 13,951.45.

On the BSE, 76,475 shares were traded in the counter so far, compared with average daily volumes of 1.44 lakh shares in the past one quarter. The stock had hit a high of Rs 36.80 and a low of Rs 36.20 so far during the day. The stock had hit a 52-week high of Rs 46.60 on 15 July 2016. The stock had hit a 52-week low of Rs 29.50 on 9 November 2016.

The mid-cap company has equity capital of Rs 1559.73 crore. Face value per share is Rs 10.

UCO Bank reported net loss of Rs 437.09 crore in Q3 December 2016 as against net loss of Rs 1497.01 crore in Q3 December 2015. Operating income declined 1.4% to Rs 4864.21 crore in Q3 December 2016 over Q3 December 2015.

The Government of India held 76.67% stake in UCO Bank as on 31 December 2016 as per the shareholding pattern.

Powered by Capital Market - Live News

Dishman Pharma extends Tuesdays sharp rally
Mar 29,2017

Meanwhile, the S&P Sensex was up 98.74 points or 0.34% at 29,508.26. The S&P BSE Mid-cap index was up 40.15 points or 0.29% at 13,951.80.

High volumes were witnessed on the counter. On the BSE, 20.19 lakh shares were traded on the counter so far as against the average daily volumes of 2.01 lakh shares in the past one quarter. The stock had hit a high of Rs 321.50 so far during the day, which is also its record high. The stock hit a low of Rs 287.95 so far during the day.

The stock had hit a 52-week low of Rs 127.60 on 24 June 2016. It had outperformed the market over the past one month till 28 March 2017, advancing 20.59% compared with the Sensexs 2.32% rise. The scrip had also outperformed the market over the past one quarter advancing 32.67% as against the Sensexs 12.2% rise.

The mid-cap company has equity capital of Rs 32.28 crore. Face value per share is Rs 2.

Shares of Dishman Pharmaceuticals & Chemicals (Dishman Pharma) have rallied 32.41% in two trading sessions from Rs 231.85 on 27 March 2017. The stock had rallied 20% to settle at Rs 278.20 yesterday, 28 March 2017 on media reports that the company has received approval from the US Food and Drug Administration (USFDA) for cancer drug Zejula Capsules.

Dish Pharma, in a clarification issued to the stock exchanges during market hours yesterday, 28 March 2017, said that the company is bound by strict confidentiality agreements with its customers and will not have any prior knowledge of the stage of development of the customers end product.

Dish Pharma further added that since it does not manufacture the innovators end product in contract research and manufacturing services (CRAMS) segment, it is Tesaro Inc., which has received the USFDA approval for cancer drug Zejula Capsules and not Dishman Pharma as mentioned in media reports.

Dishman Pharmaceuticals & Chemicals consolidated net profit rose 13.2% to Rs 50.68 crore on 7.6% decrease in net sales to Rs 356.47 crore in Q3 December 2016 over Q3 December 2015.

Dishman Pharmaceuticals & Chemicals acts as a full fledged CRAMS (contract research and manufacturing services) partner for global pharma innovators. It also makes phase transfer catalysts, Vitamin D, Vitamin D analogues, cholesterol, laolin related products, antiseptic and disinfectant formulations for pharmaceutical, cosmetic and related markets. The company also makes generic active pharmaceutical ingredients (API) and intermediates for the pharmaceutical industries.

Powered by Capital Market - Live News

Indiabulls Ventures scales 52-week high
Mar 29,2017

The announcement was made after market hours yesterday, 28 March 2017.

Meanwhile, the S&P BSE Sensex was up 112.36 points or 0.38% at 29,521.88. The S&P BSE Small-Cap index was up 64.61 points or 0.46% to 14,217.98.

On the BSE, 3.22 lakh shares were traded on the counter so far as against the average daily volumes of 9.75 lakh shares in the past one quarter. The stock had hit a high of Rs 52.90 in intraday trade, which is also a 52-week high for the stock. The stock hit a low of Rs 51 so far during the day. The stock had hit a 52-week low of Rs 13.10 on 5 April 2016.

The small-cap company has equity capital of Rs 64.04 crore. Face value per share is Rs 2.

Indiabulls Ventures announced that the board of directors at a meeting held yesterday, 28 March 2017 approved preferential offer & issue of up to 3.38 crore convertible warrants to Inuus Properties & Inuus Developers, promoter group entities.

The decision was taken to augment long-term resources of the company for meeting funding requirements for its business purposes, and as a reflection of confidence that promoters have in the future of the company,

These warrants are convertible into equivalent number of equity shares of Rs 2 each at an exercise price of Rs 43.75 per share. Total equity investments by these two investors would aggregate upto Rs 147.875 crore in the company, post conversion of warrants.

Indiabulls Ventures consolidated net profit fell 54.1% to Rs 10.59 crore on 9.6% decline in total income to Rs 96.93 crore in Q3 December 2016 over Q3 December 2015.

Indiabulls Ventures (Formerly Indiabulls Securities) is one of Indias leading capital markets companies providing securities broking and advisory services. Indiabulls Ventures also provides depository services, equity research services to its clients and offers commodities trading through a separate company. These services are provided both through on-line and off-line distribution channels.

Powered by Capital Market - Live News

Berger Paints gains as major promoter hikes stake in rejig
Mar 29,2017

Meanwhile, the S&P BSE Sensex was up 88.84 points or 0.3% at 29,498.36.

On the BSE, 87,000 shares were traded on the counter so far as against the average daily volumes of 2.92 lakh shares in the past one quarter. The stock had hit a high of Rs 236.40 and a low of Rs 229.25 so far during the day.

The stock had hit a record high of Rs 276.80 on 12 September 2016 and a 52-week low of Rs 164.29 on 28 March 2016. It had underperformed the market over the past one month till 28 March 2017, sliding 0.65% compared with the Sensexs 2.32% rise. The scrip had, however, outperformed the market over the past one quarter advancing 12.59% as against the Sensexs 12.2% rise.

The large-cap company has equity capital of Rs 97.10 crore. Face value per share is Rs 1.

KSD Family Trust sold 65 lakh shares of Berger Paints India at Rs 232 per share in a bulk deal on the BSE on 28 March 2017. GBS Dhingra Family Trust sold 65 lakh shares. U K Paints India bought the entire 1.30 crore shares.

U K Paints India controlled 48.77% stake, KSD Family Trust held 1.53% and GBS Dhingra Family Trust owned 1.28% stake in Berger Paints India end December 2016.

On consolidated basis, Berger Paints Indias net profit fell 2% to Rs 109.12 crore on 5.2% growth in net sales to Rs 1170.20 crore in Q3 December 2016 over Q3 December 2015.

Berger Paints India manufactures and markets a range of decorative and industrial paint products and has operations throughout India.

Powered by Capital Market - Live News

Rama Steel Tubes hardens after raising funds
Mar 29,2017

The announcement was made during market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 71.50 points or 0.24% at 29,481.02. The S&P BSE Small-Cap index was up 55.60 points or 0.39% to 14,208.97.

On the BSE, 3,094 shares were traded on the counter so far as against the average daily volumes of 25,748 shares in the past one quarter. The stock had hit a high of Rs 121.90 and a low of Rs 120 so far during the day. The stock had hit a record high of Rs 148 on 26 October 2016 and a 52-week low of Rs 83.95 on 6 April 2016.

The small-cap company has equity capital of Rs 7.47 crore. Face value per share is Rs 5.

Rama Steel Tubes said that its board of directors in a meet held today, 29 March 2017 approved the preferential allotment of 15 lakh fully convertible warrants (FCWs) and 11 lakh equity shares at an issue price of Rs 122 each to some promoter group and non-promoter group entities.

Rama Steel Tubes consolidated net profit rose 61.3% to Rs 2.63 crore on 43% rise in net sales to Rs 66.60 crore in Q3 December 2016 over Q3 December 2015.

Rama Steel Tubes deals in manufacturing, supplying and exporting of steel pipes, steel tubes and fittings.

Powered by Capital Market - Live News

Dilip Buildcon firms up after winning road project
Mar 29,2017

The announcement was made before market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 66.68 points, or 0.23% to 29,476.20. The S&P BSE Mid-Cap index was up 17.51 points or 0.13% to 13,929.16.

On the BSE, 4,557 shares were traded in the counter so far, compared with average daily volumes of 37,116 shares in the past one quarter. The stock had hit a high of Rs 347.80 and a low of Rs 343.65 so far during the day. The stock had hit a record high of Rs 365.15 on 21 March 2017. The stock had hit a record low of Rs 178.60 on 9 November 2016.

The mid-cap company has equity capital of Rs 136.77 crore. Face value per share is Rs 10

Dilip Buildcon (DBL) has been declared as the lowest-1 or L1 bidder for the project of four laning, rehabilitation and upgradation of NH-4 from Nalagampalli to AP/Karnataka border under the National Highways Development Project (NHDP)-IV in Andhra Pradesh on engineering, procurement and construction (EPC) mode.

The contract amount for this four lane National Highways Authority of India (NHAI) project on EPC mode in Andhra Pradesh, to be executed on EPC basis is Rs 503.10 crore with 24 months of completion period.

Dilip Buildcons net profit jumped 151.7% to Rs 108.64 crore on 41.9% rise in net sales to Rs 1388.43 crore in Q3 December 2016 over Q3 December 2015.

Dilip Buildcon is a road-focused engineering procurement construction (EPC) contractor. The company develops infrastructure across the country in diverse areas such as roads & bridges, water sanitation & sewage, irrigation, industrial, commercial & residential buildings.

Powered by Capital Market - Live News

L&T builds up after winning orders
Mar 29,2017

The announcement was made before market hours today, 29 March 2017.

Meanwhile, the S&P BSE Sensex was up 61.15 points or 0.21% at 29,470.67.

On the BSE, 5,408 shares were traded on the counter so far as against the average daily volumes of 1.33 lakh shares in the past one quarter. The stock had hit a high of Rs 1,555.50 and a low of Rs 1,548.80 so far during the day. The stock had hit a 52-week high of Rs 1,615 on 27 July 2016 and a 52-week low of Rs 1,177 on 7 April 2016.

The large-cap company has equity capital of Rs 186.59 crore. Face value per share is Rs 2.

L&T said that the power transmission and distribution business of L&T Construction recently bagged major orders worth Rs 2400 crore in the domestic and international markets.

L&Ts consolidated net profit rose 38.9% to Rs 972.47 crore on 1.7% growth in net sales to Rs 26018.15 crore in Q3 December 2016 over Q3 December 2015.

L&T is an Indian multinational engaged in technology, engineering, construction, manufacturing and financial services.

Powered by Capital Market - Live News

Hindustan Zinc drops on ex-special dividend
Mar 29,2017

Before turning ex-special dividend, the stock offered a dividend yield of 8.43% based on the closing price of Rs 326 yesterday, 28 March 2017.

Meanwhile, the S&P BSE Sensex was up 34.84 points or 0.14% at 29,451.45.

On the BSE, 2.86 lakh shares were traded on the counter so far as against the average daily volumes of 2.56 lakh shares in the past two weeks. The stock had hit a high of Rs 296.85 and a low of Rs 276.20 so far during the day. The stock had hit a record high of Rs 333.40 on 3 February 2017. The stock had hit a 52-week low of Rs 158.20 on 8 April 2016.

The large-cap company has equity capital of Rs 845.06 crore. Face value per share is Rs 2.

Hindustan Zincs net profit rose 26.1% to Rs 2319.90 crore on 46% growth in net sales to Rs 4943.89 crore in Q3 December 2016 over Q3 December 2015.

Hindustan Zinc is a subsidiary of Vedanta (formerly known as Sesa Sterlite), a part of London listed Vedanta Resources plc, a global diversified natural resources company.

Powered by Capital Market - Live News